miR-30a increases the differentiation and immunosuppressive activity of MDSCs by targeting SOCS3 and stimulating JAK2/STAT3 signaling, thereby reducing CD8+ T cells infiltration and accelerating tumor progression (60, 61). Here, CD8A is linked to neoplasm.